Brielle Benyon

Assistant managing editor at @CURE_today ( L2
Mom to the coolest kid around

[MJH Life Sciences® @MJHLifeSciences]

Honoring the brave men and women who have served our country on this #VeteransDay. We salute your sacrifice and courage. #MJHTeam #MJHLifeSciences #SPIRIT

[Bruna Pellini, MD @BrunaPellini]

📣 Let’s debunk some of the common lung cancer myths and misconceptions I hear in the clinic! #NSCLC #CancerFacts #MoffittAmbassadors @MoffittNews @MoffittResearch @lungoncdoc @oncodaily @OncBrothers

[Oncology Nursing News @OncNursingNews]

More from #ESMO24: T-DXd had PFS and ORR benefit in patients with HER2-positive metastatic breast cancer regardless of the status of brain metastases. Nancy U. Lin, MD, from @DanaFarber presented these findings from the DESTINY-Breast12 study.

[Brielle Benyon @Brielle_Benyon]

Hey! I know that place! Proud @TCNJ alumna

[TCNJ @TCNJ]

The @WSJ ranks TCNJ among the top 20% of all colleges and universities — and as the #1 public college in New Jersey — on its 2025 Best Colleges in the U.S. list.

Read more: https://t.co/j0NwrrWf1S

[Brielle Benyon @Brielle_Benyon]

Every now and then, we edit and publish something on @cure_today that — while beautifully written — gets the right in the gut. This was one of those posts. https://t.co/YxxvofMIuB

[Brielle Benyon @Brielle_Benyon]

At #SOHO24, an expert from @MDAndersonNews discusses the stem cell transplant process for patients with blood cancer. https://t.co/iyRIWSnVBr

[Brielle Benyon @Brielle_Benyon]

With #SOHO24 #WCLC24 and #ESMO24, it's going to be a BUSY September.

[Brielle Benyon @Brielle_Benyon]

Happy back-to-school time AKA sniffle season to all parents who celebrate!

[Brielle Benyon @Brielle_Benyon]

I spoke with an expert this week about the pancreatic cancer vaccine, ELI-002 7P. He said he's as excited for this as he was early CheckMate trials studying Opdivo (nivolumab) @cure_today https://t.co/niaWWttFer

[Brielle Benyon @Brielle_Benyon]

Dr. Weber was one of my very first interviews when I started at @MJHLifeSciences more than 8 years ago. He was kind, smart and — as always — impeccably dressed. I followed much of his research that shaped the treatment of melanoma as we know it today. RIP.

[CURE Today @cure_today]

CURE is saddened to learn of the death of Dr. Jeffrey S. Weber of @nyulangone. Weber was an instrumental researcher and clinician in the field of melanoma — from immunotherapy to cancer vaccines. While he will be missed, his impact on cancer care will never be forgotten.

[Brielle Benyon @Brielle_Benyon]

You can expect more on the chemo shortage from me later this week on @cure_today. Thanks to our friends at #NCCN for helping to coordinate!

[Brielle Benyon @Brielle_Benyon]

Cisplatin/carboplatin supplies are better than last year, but other cancer drugs are in shortage. However, most @NCCN member institutions won't be withholding care, the org's CMO said. https://t.co/2ZcKXnnf4E

[Brielle Benyon @Brielle_Benyon]

In a recent @cure_today Educated Patient Metastatic Breast Cancer Summit, I learned that biomarker testing is not a one-and-done process for patients with HR+ metastatic breast cancer #BCSM https://t.co/iZlRsMQIkv

[Brielle Benyon @Brielle_Benyon]

In late May, the FDA approved Retevmo for RET-positive pediatric cancers. The approval, however, is just the beginning for targeted treatments in childhood cancer, according to an expert from @SickKidsNews https://t.co/mjIn580WMk

[Brielle Benyon @Brielle_Benyon]

It was awesome covering these articles from #ASCO24 for @cure_today and seeing how they are shaping the future of cancer care. Our coverage on LAURA: https://t.co/z7gXnuu1gV

[Eric K. Singhi, MD @lungoncdoc]

Overheard at Best of #ASCO24 Albuquerque:

“Wait. Are you that doctor that dances while giving updates on lung cancer?”

Why yes, that’s me 😂

[Brielle Benyon @Brielle_Benyon]

@CancerInsider @ejgallagher1 Phuong, congrats on years of survivorship! Your work continues to make a difference in the lives of those with cancer

[Brielle Benyon @Brielle_Benyon]

This puts goal-of-care discussions and quality of life at center stage. However, it's not lost on me how difficult these kinds of convos must be between patients, caregivers and clinicians

[Brielle Benyon @Brielle_Benyon]

Had an interesting chat with @DrKerinAdelson and Maureen Canavan from @YaleCancer about cancer treatment at the end of life. Their data show that institutions that give more cancer drugs at the end of life have no better outcomes than those that don't. https://t.co/8buUds5WK4

[Brielle Benyon @Brielle_Benyon]

We're covering all these breaking news stories (and more!) on @cure_today https://t.co/VuQRXp8TyD

[Brielle Benyon @Brielle_Benyon]

Over the last week, we've seen FDA approvals in the endometrial, pediatric, thyroid and other solid cancer spaces. If that's not a sign of he field moving forward at incredible speeds, then I don't know what is! #GYNCSM #ThyroidCancer #ChildhoodCancer